< Back to previous page
Researcher
Jennyfer Bultinck
- Disciplines:Other biotechnology, bio-engineering and biosystem engineering not elsewhere classified, Medical proteomics, Medical biotechnology not elsewhere classified, Cell, tissue and organ engineering, Cellular therapy
Affiliations
- Department of Biochemistry (Department)
Member
From1 Oct 2010 → 30 Dec 2014 - Department of Biomedical molecular biology (Department)
Member
From1 Oct 2001 → 30 Nov 2005
Publications
1 - 5 of 5
- Nitric oxide production by endotoxin preparations in TLR4-deficient mice(2014)
Authors: Anje Cauwels, Jennyfer Bultinck, Renske De Zwaef, Benjamin Vandendriessche, Stefan Magez, Peter Brouckaert
Pages: 36 - 43 - TLR2 activation causes no morbidity or cardiovascular failure, despite excessive systemic nitric oxide production(2013)
Authors: Benjamin Vandendriessche, Jennyfer Bultinck, Benedicte Descamps, Elke Rogge, Tom Van Nieuwenhuysen, Christian Vanhove, Peter Brouckaert
Pages: 28 - 35 - STAT3 transcriptional activity is controlled by regulated acetylation(2011)Volume: 56
Authors: Jan Tavernier, Laura Icardi, Viola Gesellchen, Raffaele Mori, Samuel Lievens, Sven Eyckerman, Jennyfer Bultinck, M Boutros, Karolien De Bosscher
Pages: 105 - 105 - Protein-protein interactions: network analysis and applications in drug discovery
Authors: Jennyfer Bultinck, Samuel Lievens, Jan Tavernier
Pages: 4619 - 4629 - A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment
Authors: Geneviève Garcin, Jennyfer Bultinck, Franciane Paul, José Van Der Heyden, Yann Bordat, Lode De Cauwer, Elke Rogge, Gilles Uzé, Jan Tavernier
Patents
1 - 4 of 4